| NCT03000946 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Pancreatic Surgery | 2017-05-15 | PHASE3 |
| NCT02385617 | St. James´s Hospital, Ireland|University College Dublin|University of Dublin, Trinity College|G?teborg University | Esophageal Neoplasms|Stomach Neoplasms|Weight Loss|Malnutrition | 2014-01 | NA |
| NCT02384122 | Radboud University Medical Center|Jeroen Bosch Ziekenhuis|Elisabeth-TweeSteden Ziekenhuis|Catharina Ziekenhuis Eindhoven|Bernhoven Hospital|Tjongerschans hospital|Gelre Hospitals|Maasstad Hospital|Reinier de Graaf Groep|University Medical Center Groningen|Rijnstate Hospital|St. Antonius Hospital | Angiodysplasia|Vascular Malformations|Gastrointestinal Hemorrhage|Anemia | 2015-09 | PHASE3 |
| NCT03972488 | Advanced Accelerator Applications | Gastro-enteropancreatic Neuroendocrine Tumor | 2020-01-08 | PHASE3 |
| NCT02217800 | Aspireo Pharmaceuticals Limited | Acromegaly | 2013-11 | PHASE2 |
| NCT00332696 | Novartis Pharmaceuticals | Peritoneal Neoplasms|Intestinal Obstruction|Carcinomatosis | 2005-09 | PHASE2 |
| NCT00426153 | Mayo Clinic|Novartis|National Center for Research Resources (NCRR) | Polycystic Kidney, Autosomal Dominant|Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Kidney, Polycystic|Abdominal Pain | 2007-01 | PHASE2|PHASE3 |
| NCT02685709 | Chiasma, Inc. | Acromegaly | 2016-02 | PHASE3 |
| NCT04941911 | University College, London|National Institute for Health Research, United Kingdom | Liver Transplantation|Renal Failure | 2022-05-27 | PHASE2 |
| NCT00033605 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Cervical Cancer|Colorectal Cancer|Diarrhea|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Prostate Cancer|Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific|Vaginal Cancer|Vulvar Cancer | 2002-04 | PHASE3 |
| NCT00534677 | Aga Khan University | Portal Hypertension|Cirrhosis|Hematemesis|Melena | 2004-05 | PHASE4 |
| NCT03455322 | National Hepatology & Tropical Medicine Research Institute | Renal Impairment in Hepatorenal Syndrome | 2018-08-15 | PHASE4 |
| NCT00569127 | National Cancer Institute (NCI) | Colorectal Neuroendocrine Tumor G1|Gastric Neuroendocrine Tumor G1|Neuroendocrine Neoplasm|Neuroendocrine Tumor|Neuroendocrine Tumor G2 | 2007-12-01 | PHASE3 |
| NCT00145405 | Odense University Hospital | Acromegaly | 2002-09 | PHASE4 |
| NCT00241020 | Novartis Pharmaceuticals | Advanced Hepatocellular Carcinoma | 2002-06 | PHASE3 |
| NCT00595140 | Ludwig-Maximilians - University of Munich | Acromegaly | 2008-01 | PHASE4 |
| NCT00804297 | Albert Einstein Healthcare Network | Hypoglycemia|Diabetes Mellitus | 2005-06 | PHASE3 |
| NCT00171613 | Novartis | Hypothalamic Obesity | 2005-02 | PHASE4 |
| NCT07165886 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Gastroenteropancreatic Neuroendocrine Tumors | 2025-08-29 | PHASE2|PHASE3 |
| NCT00332969 | Novartis Pharmaceuticals | Thymoma | 2005-09 | PHASE2 |
| NCT00005906 | National Heart, Lung, and Blood Institute (NHLBI) | Lymphangioleiomyomatosis|Lymphangiomyomas|Pleural Effusions|Ascites | 2000-06 | PHASE2 |
| NCT03798912 | RANI Therapeutics | Healthy Volunteers | 2019-07-09 | PHASE1 |
| NCT05171751 | Beijing Children´s Hospital | Congenital Hyperinsulinaemic Hypoglycaemia|Octreotide Adverse Reaction | 2021-11-01 | |
| NCT01301222 | PVS Memorial Hospital | Pancreatic Fistula | 2010-09 | PHASE4 |
| NCT02111044 | Italfarmaco | Acromegaly | 2014-04 | PHASE2 |
| NCT00002779 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Lymphoma | 1998-02 | PHASE2 |
| NCT00004327 | National Center for Research Resources (NCRR)|Yale University | Hereditary Hemorrhagic Telangiectasia|Ectasia | 1995-01 | PHASE2 |
| NCT02474914 | Mansoura University | Periampullary Carcinoma Resectable | 2014-05 | NA |
| NCT00913055 | Endo Pharmaceuticals | Acromegaly | 2007-02 | PHASE2 |
| NCT00166725 | Novartis | Prostate Cancer | 2004-02 | PHASE2 |
| NCT00765323 | Endo Pharmaceuticals | Acromegaly | 2008-09 | PHASE3 |
| NCT00225979 | Novartis Pharmaceuticals | Acromegaly | 2002-11 | PHASE3 |
| NCT02237053 | AdventHealth Translational Research Institute | Hyperglucagonemia|Obesity | 2014-09 | PHASE1 |
| NCT03571594 | Ono Pharmaceutical Co., Ltd. | Acromegaly | 2018-06-07 | PHASE1 |
| NCT00113360 | M.D. Anderson Cancer Center|Novartis Pharmaceuticals | Neuroendocrine Carcinoma|Islet Cell Carcinoma | 2005-01 | PHASE2 |
| NCT01400100 | St. Josef Hospital Bochum | Pancreatic Fistula | 2011-08 | NA |
| NCT01561066 | Jinling Hospital, China | Enterocutaneous Fistulas|Intra-abdominal Infection | 2008-01 | PHASE1 |
| NCT03398941 | Chengfeng Wang | Pancreatic Diseases | 2018-02-01 | NA |
| NCT01578239 | Advanced Accelerator Applications | Carcinoid Tumor of the Small Bowel|Neuroendocrine Tumour | 2012-09-06 | PHASE3 |
| NCT01613495 | Oregon Health and Science University | Prader Willis Syndrome | 2005-08 | NA |
| NCT02010385 | University College Dublin | Roux-en-Y Bariatric Surgery | 2013-02 | NA |
| NCT01865760 | University of Aarhus|Region MidtJylland Denmark | Obesity|Hypoglycemia|Surgery | 2013-06 | NA |
| NCT06974344 | King Faisal Specialist Hospital & Research Center | Small-for-Size Syndrome | 2025-06-01 | PHASE4 |
| NCT02032784 | AdventHealth | Adenoma | 2014-03 | PHASE4 |
| NCT02409849 | Peking University | Gastro-entero-pancreatic Carcinoma|Esophageal Neuroendocrine Carcinoma | 2015-04 | PHASE2 |
| NCT04871204 | Fredrik Klevebro|Karolinska University Hospital | Esophageal Cancer|Gastric Cancer | 2021-06-16 | PHASE2 |
| NCT01871844 | Italfarmaco | Healthy Male Volunteers | 2012-01 | PHASE1 |
| NCT06062719 | National Hepatology & Tropical Medicine Research Institute | Non-variceal Gastrointestinal Bleeding | 2023-08-23 | PHASE2|PHASE3 |
| NCT03541447 | Mario Negri Institute for Pharmacological Research|Otsuka Pharmaceutical Italy S.r.l. | Autosomal Dominant Polycystic Kidney Disease | 2018-12-12 | PHASE2 |
| NCT04353193 | Juan A. Arnaiz | Liver Cirrhosis Portal | 2020-06 | PHASE4 |
| NCT00690430 | Novartis Pharmaceuticals | Symptomatic Refractory Resistant Carcinoid Disease | 2008-04 | PHASE3 |
| NCT01567488 | Grupo Espanol de Tumores Neuroendocrinos | Gastrointestinal Neoplasms | 2011-06-08 | PHASE2 |
| NCT00376064 | Novartis Pharmaceuticals | Acromegaly | 2006-03 | PHASE4 |
| NCT00953394 | University of Turin, Italy | Neuroendocrine Tumors | 2002-02 | PHASE2 |
| NCT05724134 | Columbia University|Albert Einstein College of Medicine|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance|Prediabetic State|Hyperinsulinemia|Non-Alcoholic Fatty Liver Disease|Obesity | 2023-08-29 | PHASE1 |
| NCT04129255 | National Cancer Institute, Naples | Neuroendocrine Tumors | 2017-06-28 | PHASE2 |
| NCT06558422 | Columbia University|University of California, Berkeley|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance|Hyperinsulinemia|Metabolic Dysfunction Associated Steatotic Liver Disease|Non-Alcoholic Fatty Liver Disease|Prediabetic State|Obesity | 2027-01-01 | PHASE1 |
| NCT00386984 | University Hospital Freiburg|German Federal Ministry of Education and Research|Deutsche Krebshilfe e.V., Bonn (Germany)|Novartis | Carcinoma, Hepatocellular | 1999-10 | PHASE3 |
| NCT05683444 | Rigshospitalet, Denmark|University of Aarhus|Bispebjerg Hospital | Lymphatic Diseases|Chylothorax | 2020-07-01 | EARLY_PHASE1 |
| NCT05884255 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Gastroenteropancreatic Neuroendocrine Tumor | 2023-07-06 | PHASE3 |
| NCT03031535 | Dauntless Pharmaceuticals | Healthy Volunteer Study | 2017-01 | PHASE1 |
| NCT01229943 | National Cancer Institute (NCI) | Advanced Pancreatic Neuroendocrine Tumor|Locally Advanced Pancreatic Neuroendocrine Tumor|Pancreatic Gastrinoma|Pancreatic Neuroendocrine Tumor G1|Pancreatic Neuroendocrine Tumor G2|Pancreatic Vipoma | 2010-10-15 | PHASE2 |
| NCT00242541 | Novartis Pharmaceuticals | Acromegaly | 2003-03 | PHASE4 |
| NCT05761431 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Acromegaly | 2023-03-02 | PHASE1 |
| NCT03289741 | Memorial Sloan Kettering Cancer Center | Neuroendocrine Tumors | 2017-09-19 | PHASE4 |
| NCT01204476 | National Cancer Institute (NCI) | Gastrin-Producing Neuroendocrine Tumor|Lung Carcinoid Tumor|Metastatic Digestive System Neuroendocrine Tumor G1|Pancreatic Glucagonoma|Pancreatic Insulinoma|Pancreatic Polypeptide Tumor|Paraganglioma|Recurrent Digestive System Neuroendocrine Tumor G1|Recurrent Merkel Cell Carcinoma|Recurrent Pancreatic Neuroendocrine Carcinoma|Regional Digestive System Neuroendocrine Tumor G1|Somatostatin-Producing Neuroendocrine Tumor|Stage III Merkel Cell Carcinoma|Stage IV Merkel Cell Carcinoma|Thyroid Gland Medullary Carcinoma | 2010-10 | PHASE1 |
| NCT00108355 | US Department of Veterans Affairs | Ascites|Cirrhosis | 2003-12 | PHASE4 |
| NCT03179995 | Fox Chase Cancer Center | Major Liver Resection | 2017-07-07 | PHASE2 |
| NCT00248131 | Novartis Pharmaceuticals | Diabetic Retinopathy | 2005-11 | PHASE3 |
| NCT03891849 | Centre Hospitalier Universitaire, Amiens | Haemorrhagic Shock|Variceal Hemorrhage | 2021-09-01 | NA |
| NCT02381249 | St. James´s Hospital, Ireland|University College Dublin|University of Dublin, Trinity College|G?teborg University | Esophageal Neoplasms|Stomach Neoplasms|Weight Loss|Malnutrition|Pancreatic Neoplasms|Duodenal Neoplasms | 2015-03 | NA |
| NCT00884715 | Endo Pharmaceuticals | Carcinoid Syndrome | 2009-07 | PHASE1|PHASE2 |
| NCT07479784 | Shanghai Zhongshan Hospital | Pancreatic Fistula | 2026-04-01 | PHASE3 |
| NCT03624517 | Medical University of South Carolina|Ohio State University|University of Texas Southwestern Medical Center|University of Florida Health | Esophageal Varices|Liver Cirrhoses|Bleeding Esophageal Varices|Upper Gastrointestinal Bleeding | 2018-09-19 | PHASE4 |
| NCT02874326 | Radboud University Medical Center|St. Antonius Hospital | Hereditary Hemorrhagic Telangiectasia|Gastrointestinal Hemorrhage|Anemia | 2016-10 | PHASE2 |
| NCT00250796 | University of New Mexico | Liver|Cancer | 2000-09 | PHASE2 |
| NCT05050942 | Camurus AB | Gastro-enteropancreatic Neuroendocrine Tumor | 2021-10-22 | PHASE3 |
| NCT02457156 | University of Liverpool|Cancer Research UK | Pancreatic Cancer | 2015-04-23 | PHASE3 |
| NCT06865677 | National Cancer Institute (NCI) | Recurrent Platinum Resistant Epithelial Ovarian Carcinoma|Recurrent Epithelial Endometrial Carcinoma|Recurrent Epithelial Cervical Carcinoma | 2025-06-09 | PHASE2 |
| NCT06240039 | University of Copenhagen|Bispebjerg Hospital | Non-Alcoholic Fatty Liver Disease|Obesity | 2024-02-11 | NA |
| NCT05340192 | Duke University | Healthy | 2019-09-24 | PHASE1 |
| NCT00853047 | Lexicon Pharmaceuticals | Carcinoid Syndrome | 2009-03 | PHASE2 |
| NCT00004895 | Northwestern University|National Cancer Institute (NCI) | Colorectal Cancer|Constipation, Impaction, and Bowel Obstruction|Extrahepatic Bile Duct Cancer|Gastric Cancer|Gastrointestinal Stromal Tumor|Nausea and Vomiting|Ovarian Cancer|Pancreatic Cancer|Peritoneal Cavity Cancer|Small Intestine Cancer | 1999-10 | PHASE2 |
| NCT02333565 | Assistance Publique Hopitaux De Marseille | Recurrent Meningiomas|Resistant Meningiomas | 2015-01-22 | PHASE2 |
| NCT00742339 | University of Padova | Cirrhosis|Hepatorenal Syndrome | 2005-05 | PHASE2|PHASE3 |
| NCT00008073 | University of Pittsburgh|National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 1996-01 | PHASE1 |
| NCT03846180 | General Hospital of Shenyang Military Region | Variceal Hemorrhage|Cirrhosis, Liver|Kidney Injury | 2019-03-01 | |
| NCT00171886 | Novartis Pharmaceuticals | Acromegaly | 2002-07 | PHASE4 |
| NCT02374632 | Hvidovre University Hospital|University of Copenhagen | Bariatric Surgery (Gastric Bypass)|Severe Obesity | 2014-10 | PHASE4 |
| NCT02437825 | Hadassah Medical Organization | Fistula; Salivary Duct or Gland | 2015-10 | PHASE2 |
| NCT00227773 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Gastrointestinal Carcinoid Tumor|Islet Cell Carcinoma | | PHASE2 |
| NCT01538966 | Cedars-Sinai Medical Center | Acromegaly | 2012-03-29 | NA |
| NCT00412061 | Novartis Pharmaceuticals | Carcinoid Tumor|Malignant Carcinoid Syndrome | 2006-12 | PHASE3 |
| NCT00466856 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) | Head and Neck Cancer|Islet Cell Tumor|Metastatic Cancer|Pheochromocytoma | 2003-12 | PHASE2 |
| NCT00002253 | Sandoz | Diarrhea|HIV Infections | | NA |
| NCT06126354 | Columbia University|Albert Einstein College of Medicine|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance|Prediabetic State|Non-Alcoholic Fatty Liver Disease|Overweight and Obesity | 2024-07-01 | PHASE1 |
| NCT06881888 | University of Alabama at Birmingham | Diabetic Macular Edema | 2026-08-31 | PHASE1 |
| NCT00171873 | Carmen Schade-Brittinger | Neuroendocrine Tumors | 2001-09 | PHASE3 |
| NCT00262470 | Satish R. Raj|National Center for Advancing Translational Sciences (NCATS) | Tachycardia|Chronic Orthostatic Intolerance | 1997-04 | PHASE1|PHASE2 |
| NCT01917773 | Indiana University | Colonic Motility Index|Constipation | 2013-08 | PHASE4 |
| NCT00003283 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Thymoma and Thymic Carcinoma | 1998-10-13 | PHASE2 |
| NCT06254235 | Qilu Pharmaceutical Co., Ltd. | Healthy Volunteers | 2021-06-16 | PHASE1 |
| NCT00128232 | Novartis | Acromegaly | 2002-12 | PHASE3 |
| NCT06085976 | Clinica Universidad de Navarra, Universidad de Navarra | Hepatic Carcinoma|Hepatic Metastasis | 2023-08-14 | PHASE2 |
| NCT00463983 | Institut National de la Santé Et de la Recherche Médicale, France | Idiopathic Pulmonary Fibrosis | 2006-10 | PHASE1|PHASE2 |
| NCT02217839 | Aspireo Pharmaceuticals Limited | Healthy | 2012-04 | PHASE1 |
| NCT00003057 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI)|SWOG Cancer Research Network|Cancer and Leukemia Group B | Colorectal Cancer|Diarrhea | 1997-03-26 | PHASE3 |
| NCT00006269 | Novartis | Colorectal Cancer|Diarrhea | 1999-12 | PHASE3 |
| NCT00131144 | Novartis | Diabetic Retinopathy | 1999-11 | PHASE3 |
| NCT03734627 | St. James´s Hospital, Ireland | Esophageal Cancer|Nutrition Disorders|Appetite Disorders|Dumping Syndrome|Delayed Gastric Emptying|Surgery | 2016-07-01 | |
| NCT06878664 | Grupo Espanol de Tumores Neuroendocrinos|Grupo Espa?ol de Tumores Neuroendocrinos y Endocrinos (GETNE) | Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs) | 2025-06-12 | PHASE3 |
| NCT06193616 | Mario Negri Institute for Pharmacological Research | Autosomal Dominant Polycystic Kidney | 2024-02-12 | |
| NCT01295060 | Endo Pharmaceuticals | Acromegaly | 2011-02 | PHASE3 |
| NCT03061604 | Theodor Bilharz Research Institute|Université Libre de Bruxelles | Variceal Hemorrhage | 2014-11 | NA |
| NCT01188733 | Mayo Clinic | Cirrhosis|Portal Hypertension|Esophageal Varices | 1998-06 | PHASE1|PHASE2 |
| NCT01203306 | University of Turin, Italy | Neuroendocrine Carcinomas | 2006-01 | PHASE2 |
| NCT01371643 | NYU Langone Health | Pituitary Adenoma | 2004-04 | PHASE4 |
| NCT00427349 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Neoplastic Syndrome | 2008-11-07 | PHASE2 |
| NCT01469338 | University of Southern California|National Cancer Institute (NCI)|Sanofi | Diarrhea|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer | 2012-07 | PHASE2 |
| NCT05459844 | Sinotau Pharmaceutical Group | Neuroendocrine Tumors | 2022-08-31 | PHASE3 |
| NCT02916433 | Danbury Hospital | Octreotide|Sputum | 2016-09 | PHASE2 |
| NCT00075868 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) | Anal Cancer|Colorectal Cancer|Drug+Agent Toxicity by Tissue+Organ|Radiation Enteritis | 2003-12 | PHASE3 |
| NCT01137682 | Novartis Pharmaceuticals | Acromegaly | 2010-07-19 | PHASE3 |
| NCT00223691 | Vanderbilt University | Autonomic Failure|Orthostatic Hypotension | 2002-03 | PHASE1 |
| NCT05477576 | RayzeBio, Inc. | GEP-NET|Gastroenteropancreatic Neuroendocrine Tumor|Gastroenteropancreatic Neuroendocrine Tumor Disease|Neuroendocrine Tumors|Carcinoid|Carcinoid Tumor|Pancreatic NET | 2022-03-24 | PHASE3 |
| NCT04027348 | Roswell Park Cancer Institute | Malignant Bowel Obstruction | 2019-06-26 | PHASE2 |
| NCT00966355 | Korea University | Variceal Bleeding, Cirrhosis | 2006-09 | PHASE4 |
| NCT00399893 | Duke University|National Institutes of Health (NIH)|National Center for Research Resources (NCRR)|Novartis | Prader-Willi Syndrome | 2006-12 | NA |
| NCT02299089 | Camurus AB|Novartis | Acromegaly|Neuroendocrine Tumors | 2015-01 | PHASE2 |
| NCT01707225 | Virginia Commonwealth University|Thoratec Corporation|Novartis | Gastrointestinal Bleeding | 2013-02 | PHASE1 |
| NCT00372697 | Novartis Pharmaceuticals | Acromegaly | 2005-12 | PHASE3 |
| NCT00002967 | NSABP Foundation Inc|National Cancer Institute (NCI) | Breast Cancer | 1997-05 | PHASE3 |
| NCT00432068 | Novartis Pharmaceuticals | Healthy Cholecystectomized | 2007-01 | PHASE1 |
| NCT00002252 | Sandoz | Diarrhea|HIV Infections | | NA |
| NCT00552071 | Cedars-Sinai Medical Center|Novartis Pharmaceuticals | Acromegaly | 2007-07 | PHASE4 |
| NCT03520569 | University of Virginia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Vascular Stiffness|Insulin Sensitivity | 2019-02-04 | EARLY_PHASE1 |
| NCT02195635 | Lexicon Pharmaceuticals | Drug Interactions | 2014-07 | PHASE1 |
| NCT02977897 | University Health Network, Toronto | Diarrhea|Immunosuppression | 2017-01 | |
| NCT00170742 | Novartis | Proliferative Diabetic Retinopathy | 2003-12 | PHASE3 |
| NCT00600886 | Novartis Pharmaceuticals | Acromegaly | 2008-02-11 | PHASE3 |
| NCT01029275 | University Hospital, Rouen | Acromegaly | 2005-01 | NA |
| NCT00240045 | University of Alberta|Novartis | Type 2 Hepatorenal Syndrome|Refractory Ascites | 2005-10 | PHASE2|PHASE3 |
| NCT00781911 | Eli Lilly and Company | Carcinoma|Neuroendocrine Tumors | 2009-02 | PHASE2 |
| NCT00521300 | St. Olavs Hospital|Novartis | Acromegaly | 1999-09 | PHASE4 |
| NCT02305069 | University of Nottingham|Biotechnology and Biological Sciences Research Council | Obesity|Sarcopenia | 2009-10 | NA |
| NCT05199038 | Tanta University | Esophageal Varices | 2022-06 | PHASE4 |
| NCT07057622 | HTA Co., Ltd. | NETS Ga68 Lu177 | 2023-12-12 | PHASE3 |
| NCT01587222 | Anna Cruceta | Fibrosis|Renal Failure|Hepatorenal Syndrome | 2016-07 | PHASE2 |
| NCT00616551 | Ambrilia Biopharma, Inc. | Acromegaly | 2007-04 | PHASE3 |
| NCT02217826 | Aspireo Pharmaceuticals Limited | Healthy | | PHASE1 |
| NCT00274170 | C.R.Darnall Army Medical Center | Migraine Headache | 2006-01 | PHASE1|PHASE2 |
| NCT06592261 | Columbia University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Pisa | Insulin Resistance|Hyperinsulinemia|Obesity|Healthy | 2024-09-16 | PHASE1 |
| NCT04028323 | Nanfang Hospital, Southern Medical University|LanZhou University|Zhongda Hospital|Guangdong Second Provincial General Hospital|Xingtai People´s Hospital|Affiliated Hospital of Jiangsu University|Tianjin Second People´s Hospital|The Second Hospital of Anhui Medical University|The Sixth People´s Hospital of Shenyang|The Second Affiliated Hospital of Baotou Medical College | Renal Function Disorder|Acute Variceal Bleeding | 2019-07-16 | PHASE4 |
| NCT02119884 | Shanghai Zhongshan Hospital|Shandong Provincial Hospital | Gastric and Esophageal Varices | 2014-02 | PHASE4 |
| NCT05682209 | Ikechukwu Bartholomew Ulasi | Seroma Following Procedure | 2020-12-18 | PHASE4 |
| NCT06784752 | Novartis Pharmaceuticals | Somatostatin Receptor Positive (SSTR&addition;)|Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) | 2025-05-30 | PHASE3 |
| NCT02294006 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Well Differentiated Pancreatic Endocrine Tumor | 2014-06 | PHASE2 |
| NCT06300216 | Qilu Hospital of Shandong University | Neuroendocrine Tumors | 2024-03-26 | |
| NCT03057509 | Massachusetts General Hospital | Small Bowel Carcinoid Tumor | 2018-11 | PHASE1 |
| NCT01086982 | Azidus Brasil | Acromegaly | 2010-03 | PHASE1 |
| NCT02668588 | Chemi S.p.A. | Seroma | 2015-10-22 | PHASE2 |
| NCT07460908 | Lahore General Hospital | Hepatorenal Syndrome | 2025-05-01 | NA |
| NCT00088582 | Novartis Pharmaceuticals | Acromegaly | 2004-03 | PHASE2 |
| NCT02920567 | Saint Vincent´s Hospital, Korea | Periampullary Tumors | 2014-01 | NA |
| NCT03812939 | Peking Union Medical College Hospital | Gastric NET | 2019-01-01 | |
| NCT03879694 | Roswell Park Cancer Institute|NeuroEndocrine Tumor Research Foundation (NETRF) | Lung Atypical Carcinoid Tumor|Lung Typical Carcinoid Tumor|Metastatic Pancreatic Neuroendocrine Tumor | 2019-06-17 | PHASE1 |
| NCT04048707 | University of California, Los Angeles | Hepatorenal Syndrome|Cirrhosis|Kidney Failure, Acute | 2021-07-01 | PHASE2 |
| NCT01157858 | Radboud University Medical Center|Novartis | Polycystic Liver Disease | 2010-06 | PHASE2 |
| NCT00582426 | Novartis Pharmaceuticals | Chemotherapy-induced Diarrhea | 2008-04 | PHASE3 |
| NCT00257426 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) | Liver Cancer | 2005-07 | PHASE2 |
| NCT00182754 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific | 2005-10 | PHASE3 |
| NCT01412424 | Chiasma, Inc. | Acromegaly | 2012-03 | PHASE3 |
| NCT03252353 | Chiasma, Inc. | Acromegaly | 2017-09-01 | PHASE3 |
| NCT01886287 | H. Lee Moffitt Cancer Center and Research Institute|Novartis | Neuroendocrine Carcinoma | 2013-12 | PHASE2 |
| NCT02235987 | Aspireo Pharmaceuticals Limited | Acromegaly | 2012-10 | PHASE2 |
| NCT00363051 | Novartis Pharmaceuticals | Islet Cell Carcinoma|Neuroendocrine Carcinoma|Neuroendocrine Tumor|Pancreatic Neoplasms | 2006-06 | PHASE2 |
| NCT00248157 | Novartis Pharmaceuticals | Diabetic Retinopathy | 2005-11 | PHASE3 |
| NCT01480986 | Peking University | Progression Free Survival of the Treatment | 2011-09 | PHASE2 |
| NCT02294786 | Novartis Pharmaceuticals | Cancer | 2014-12-17 | PHASE2 |